SEATTLE, WA -- (Marketwired) -- 05/21/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company�, is sponsoring two screenings of the new film Decoding Annie Parker at the Seattle International Film Festival on June 6 and 8, 2013.

SEATTLE, WA -- (Marketwired) -- 05/20/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company�, today announced that Dr.

Atossa Genetics Inc., a Seattle developer of diagnostic tests and treatments for breast cancer, reported its first-quarter loss grew to $1.9 million, or a loss of 14 cents per share, from a loss of $1.1 million, or a loss of 9 cents a share, a year ...

Atossa Genetics, Inc. (NASDAQ:ATOS) operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States closed down in its previous session ...

SEATTLE, WA -- (Marketwired) -- 04/29/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company�, will display its ForeCYTE Breast Health Test at the 61st Annual Clinical Meeting of the American Congress of Obstetrics and Gynecology in ...

SEATTLE, WA--(Marketwired - May 15, 2013) - Atossa Genetics, Inc. ( NASDAQ : ATOS), the Breast Health Company�, today announced its first quarter 2013 financial results and corporate developments.

SEATTLE, WA -- (Marketwired) -- 05/02/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company�, has signed an agreement with Millennium HealthCare Inc. (PINKSHEETS: MHCC) for the distribution by Millennium Medical Devices of ...

SEATTLE, WA -- (Marketwired) -- 04/23/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company�, believes that new recommendations published on April 16 by the U.S.

NASDAQ Decliners Watch List: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Atossa Genetics, Inc. (NASDAQ:ATOS), and STEC, Inc. (NASDAQ:STEC) Added to Growing Stock Report's NASDAQ Decliners ...

Questcor Pharmaceuticals, Inc. (QCOR) gained another 4.90 to 42.40, or 13%, on 4.3 million shares. TearLab Corporation (TEAR), one of our swing trades, jumped 1.38 to 9.34, or 17%, on 2.4 million shares.